Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Express Scripts Inc., Monster Beverage Corporation, and Biogen Idec Inc. Are Today's 3 Worst Stocks

By John Divine - Jul 16, 2014 at 7:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healthcare takes a hit once again; takeover rumors don't prevent a pullback -- here are the three worst performers in the stock market today.

Seven of the stock market's 10 sectors finished higher today, as a second day of testimony from Federal Reserve Chairwoman Janet Yellen served to assure investors that interest rates will remain low indefinitely. With that in mind, stocks seem to be the most appealing asset class, a fact that was of no comfort to shareholders in Express Scripts ( ESRX ), Monster Beverage Corporation ( MNST 3.10% ), and Biogen Idec ( BIIB 1.21% ) today. These three stocks were three of the worst performers in the S&P 500 Index ( ^GSPC 2.07% ) on Wednesday, even as the S&P itself added 8 points, or 0.4%, to finish at 1,981.

Pharmacy benefits manager Express Scripts managed to lose 3.1% today, despite few breaking developments that could be considered bearish. The biggest knock on the company from Wall Street's point of view was simply that Express Scripts hails from the health care sector, which was the worst performing sector in the stock market today. The company recently made changes to its coverage policy, dropping roughly 1,000 ingredients used in the compounding process, whereby two or more drugs are combined to create a customized medicine. This should help Express Scripts control costs in the long-run.

Monster is crushing it in the U.S., but can it take its dominance abroad? Image Source: Monster Beverage

Shares of the largest U.S. energy drink maker by volume, Monster Beverage, fell 2.9% today. Although buyout rumors are swirling and the usual talking heads are jabbering on about its potential acquisition, all that speculation hasn't even managed to send the stock higher recently, and Monster Beverage is actually on a three-day losing streak. Zooming out a bit, however, Monster does have a number of things going for it, as evidenced by its most recent blowout quarter. Consumers are losing their taste for sodas, yet energy drinks are becoming more popular than ever. Monster has a strong brand and great distribution in the U.S. and it's working on taking its empire global. Admittedly, shares appear a little frothy right now, but the underlying business is phenomenal.

The biotech industry has taken somewhat of a beating this week, and shares of Biogen Idec weren't immune to punishment on Wednesday, shedding 2.7%. Considering the contents of a report that accompanied Janet Yellen's testimony before Congress yesterday, today's losses aren't so shocking. The Fed's report specifically mentioned biotech stocks and social media stocks as being overvalued, an unusual comment for the central bank to make. While Biogen Idec's financial health appears to be perfectly acceptable, the stock, which trades at 37 times earnings, probably won't be the first one value investors look to for a bargain.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
^GSPC
$4,686.75 (2.07%) $95.08
Express Scripts Holding Company Stock Quote
Express Scripts Holding Company
ESRX
Monster Beverage Corporation Stock Quote
Monster Beverage Corporation
MNST
$88.37 (3.10%) $2.66
Biogen Inc. Stock Quote
Biogen Inc.
BIIB
$226.83 (1.21%) $2.72

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
652%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/08/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.